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EDITORIAL
Tobacco kills 4.2 million people annually. The WHO forecasts
that it will kill over 10 million per year by the late 2020s unless
robust steps to curb the epidemic are taken immediately.1
Tobacco use has been stated to be the leading cause of
preventable death worldwide.2 Annually, smoking accounts for
approximately 400 000 deaths in the USA,2 120 000 in the UK,1
500 000 in Europe,2 and in developing countries such as India
and China, 800 000 and 750 000, respectively.3,4 Smoking is
therefore a highly formidable, but preventable, cause of
extensive sickness and death.
It is necessary to appreciate that following major initial
rises, there has recently been a decrease in the proportion of
adult smokers in a number of developed countries. For
example, in the USA the percentage of adult smokers fell from
42% to 25% between 1965 and 1990.5 In the UK the proportion
decreased to 28%, but may now be increasing.1 Unfortunately,
as is apparent, a high proportion of adults continue to smoke.
Considerable increases have occurred among the young, in
particular among high school pupils. Examples of present
proportions of middle and high school students who smoke in
the USA are 38.1% for boys and 31.4% for girls,6 in the UK
28.1% and 33.1%,7 and in Switzerland, 23% and 27%.8
With regard to the situation in developing countries, a very
informative study in India of relatively young university staff,
i.e. with a high level of education, revealed that 51% of males
and 33% of females smoked.9 In some regions of India smoking
incidence is very high among men, as in Bangladesh, where the
figure stands at 49%.10 In Africa the practice has a low
occurrence rate in some countries, e.g. in Senegal and Tanzania,
but recently attention has been drawn to ‘Africa’s rising
epidemic’. 11 In Tunis, North Africa, the proportion of male
smokers has been reported to be very high (55.6%), although it
is far lower among women (5.2%).12 A study in Chad, Central
Africa, found that 24% of men aged 25 years and older were
smokers, but in men older than 45 years the figure was 40%.13
In South Africa, a national study of urban dwellers in 199614
revealed that among those aged 18 years and over the
proportion of male and female smokers was as follows: Indians
61% and 7%, coloureds 58% and 59%, blacks 53% and 10%, and
whites 52% and 17%. A recent inter-ethnic enquiry among
urban pregnant women found that 4% of black women and 3%
of Indian women were smokers, while the figure was
considerably higher among pregnant coloured women (47%).15
When did this disastrous menace to public health begin?
Historically, in 1595 Sir Walter Raleigh brought tobacco back
from the so-called New World, and popularised its use in
England.16 Interestingly, it has been related that Raleigh’s
servant, ‘on first seeing the smoke drifting from Raleigh’s
mouth, doused his employer with a bucket of water, sensibly
reasoning that where there was smoke there must be fire’.17 In
1664, King James I of England described the smoking of
tobacco as ‘a custome lothsome to the eye, hateful to the Nose,
harmefull to the braine, dangerous to the Lungs, and in the
blacke stinking fume thereof, neerest resembling the horrible
Stigian smoke of the pit that is bottomlesse’.18
From early times, tobacco smoking has been accompanied
by warnings. Thus, in 1699, King Louis XIV of France asked
‘whether the frequent use of tobacco shortened life?’16 The view
that it did, however, failed to hinder great increases in the
practice. Centuries later, before 1900, cigarette smoking became
very popular in many developed countries. As an illustration
of the progressive increases, in the USA the per capita national
rate of smoking increased enormously among smokers from an
average of 40 cigarettes a year in 1880 to 12 854 cigarettes in
1977.19 As a further indication, per capita, the annual
consumption of cigarettes was under 100 in 1910, almost 400 in
1920, but rose to nearly 1 000 in 1930.16 In recent years, despite
the decreases mentioned, as in the USA5 and the UK,1  a quarter
or so of adults remain smokers.
Healthwise, are the morbidity/mortality consequences of
smoking being adequately rated? It is insufficiently appreciated
that smoking is a causative factor in numerous cancers, as well
as in cardiovascular diseases. The cancers concerned are lung,
upper respiratory tract, bladder, oesophagus, stomach, kidney,
and blood (leukaemia).16 Smokers are far more prone to die
from these diseases than those who have never smoked. With
regard to cardiovascular diseases, heavy smokers have a
relative risk of stroke 2 - 4 times greater than that of non-
smokers.20
The salient question is — are individuals making
meaningful attempts to stop smoking? The situation is
complex.21 In the UK, it has been stated that most smokers do
not view themselves as being at increased risk for cancer or
heart disease.22 Notwithstanding, a major enquiry revealed that
69% of adult smokers would like to give up the practice.6 In a
similar study in the USA, 70% wished to quit, but only 5%
succeeded in doing so within a year.23 In developing countries
appreciation of the dangers of smoking appear to be minimal.
For example, studies from China revealed that 60% of adults
did not know that smoking can cause lung cancer, and 96% did
not know that it can promote heart disease.24
Although many have written of the dangers to health of
passive smoking,25 this has now been questioned.26 However,
the controversy continues.27
An important aspect to appreciate is that, on the one hand,
life expectancy has increased considerably in recent years;
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indeed, according to the Lancet, ‘survival to 100 years or more
may become the norm’.28 On the other hand, and in strong
contrast, the years of ‘wellness’ and of ‘healthy life expectancy’
are not increasing, and may be diminishing.29 It is of public
health concern that in addition to the major debilitating effects
of smoking, the sequelae of other powerful health/disease
factors have also become increasingly adverse. This applies
particularly to the worldwide rise in the prevalence of obesity,30
and to the major reduction in physical activity.31
Of relevance to populations in Africa, is the fact that in the
USA African Americans who smoke are more prone to die from
that cause than white American smokers.32 However, it is
imperative to face the fact that the chances of significantly
reducing morbidity and mortality from smoking in developing
populations, such as those in Africa, are small.
What precisely can the State do to reduce smoking practice?
Understandably, this bears on the highly practical question of
the ramifications of smoking on a country’s product revenue.
Very remarkably, the need to address this situation arose well
over a century ago. In France, Napoleon III said of smoking,
‘This vice brings in one hundred million francs in taxes every
year. I will certainly forbid it at once — as soon as you can
name a virtue that brings in as much revenue.’33 in 1962 the
Royal College of Physicians published its incrimination of
cigarette sales and cigarette sales fell by 10% — however 6
months later they had risen above their previous level.34 Yet, at
that time, a government committee of ministers in the UK,
headed by the science minister, Lord Hailsham, rejected the
proposed health warnings on packets, arguing that ‘there was
no scientific evidence of a connection between tar and nicotine
and lung cancer’. Furthermore, regarding the £800 million a
year revenue derived from tobacco, Selwyn Lloyd, Chancellor
of the Exchequer, stated that ‘any action likely to lead to a
sudden and substantial reduction in this figure would need to
be considered in its fiscal as well as in its political and health
aspects’.35 Fascinatingly, a closely analogous situation arose
very recently, in 2002. At the International Framework
Convention on Tobacco Control, one of the many suggestions
made was for ‘manufacturers to put health warnings on at least
30%, and preferably 60%, of a cigarette pack’.36
However, at the meeting this suggestion was opposed by
the USA, Germany, China and Japan. One acid comment made
was that ‘although the US has strict tobacco control compared
with most other countries, it was the object of suspicion
throughout the negotiations’. Furthermore, at the meeting, the
body, ‘Anti-Smoking Campaigns, charged that Bush is more
interested in protecting the profits of the world’s biggest
exporter than in the health of the poor’.36 Previously in 1995, it
was reported that while the USA has ‘some of the most
aggressive antismoking policies in the world . . . the US is also
the world’s largest exporter of cigarettes’.37
Here, then, is a gigantic worldwide morbidity/mortality
problem, associated with many millions of deaths, within the
bounds of control — yet worsening. The current situation is
indeed far removed from the expressed desire to reduce the
prevalence of smoking among adults to 12% or less.2
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